Cargando…
Profound remission in Crohn’s disease requiring no further treatment for 3–23 years: a case series
BACKGROUND: Crohn’s disease (CD) is rising in incidence and has a high morbidity and increased mortality. Current treatment use immunosuppressives but efficacy is suboptimal, and relapse is common. It has been shown that there is an imbalance present in the gut microbiome (dysbiosis) in CD with a po...
Autores principales: | Agrawal, Gaurav, Clancy, Annabel, Huynh, Roy, Borody, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144342/ https://www.ncbi.nlm.nih.gov/pubmed/32308741 http://dx.doi.org/10.1186/s13099-020-00355-8 |
Ejemplares similares
-
Targeted Combination Antibiotic Therapy Induces Remission in Treatment-Naïve Crohn’s Disease: A Case Series
por: Agrawal, Gaurav, et al.
Publicado: (2020) -
Anti-Mycobacterial Antibiotic Therapy Induces Remission in Active Paediatric Crohn’s Disease
por: Agrawal, Gaurav, et al.
Publicado: (2020) -
Crohn’s strictures open with anti-mycobacterial antibiotic therapy: A retrospective review
por: Collyer, Rhys, et al.
Publicado: (2020) -
Putting Crohn’s on the MAP: Five Common Questions on the Contribution of Mycobacterium avium subspecies paratuberculosis to the Pathophysiology of Crohn’s Disease
por: Agrawal, Gaurav, et al.
Publicado: (2020) -
Combining infliximab, anti-MAP and hyperbaric oxygen therapy for resistant fistulizing Crohn's disease
por: Agrawal, Gaurav, et al.
Publicado: (2015)